Back to STATE STREET CORP STATE STREET CORP

RPRXRPRX
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ROYALTY PHARMA PLC

STATE STREET CORP holds 11M shares of RPRX (ROYALTY PHARMA PLC), worth $527.2M as of 2026-Q1. The position was increased (+3.2% shares). RPRX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$527.2M

Current Shares

11M

Total Value Change

+$277M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
11M
+3.2%
$527.2M0.0%$47.48
32
2025-Q4
Increased
10.6M
+3.7%
$411.5M0.0%$38.99
32
2025-Q3
Increased
10.3M
+0.8%
$362.4M0.0%$35.05
31
2025-Q2
Increased
10.2M
+7.1%
$367.3M0.0%$35.46
33
2025-Q1
Decreased
9.5M
-2.5%
$296.2M0.0%$30.80
0
2024-Q4
Increased
9.8M
+2.6%
$248.9M0.0%$24.70
32
2024-Q3
Increased
9.5M
+0.3%
$269.2M0.0%$27.29
31
2024-Q2
Increased
9.5M
+4.3%
$250.2M0.0%$25.32
32

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used